Nasdaq

Recursion Pharmaceuticals to Report Q4 Earnings: What's in the Cards?

Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...
Just Auto

Posco makes strategic investment in US-based ASSB materials firm Factorial

Posco Future M’s cathode material plant in Pohang, South Korea. Posco Future M, the battery materials subsidiary of South Korea’s steel and chemicals firm Posco Group, announced it has made a ...
IEEE

FRM-CIM: Full-Digital Recursive MAC Computing in Memory System Based on MRAM for Neural Network Applications

Abstract: Computing in memory (CIM) realizes energy-efficient neural network algorithms by implementing highly parallel multiply-and-accumulate (MAC) operation. However, the MAC delay of CIM will ...
Nasdaq

Factorial Energy Plans IPO: What It Means for QS and SLDP

The solid-state battery race is heating up. Factorial Energy, a Massachusetts-based start-up, plans to go public in mid-2026. The listing will provide $100 million in capital to advance its battery ...
Business Wire

POSCO Future M Signs MOU with U.S.-based Factorial for All-Solid-State Battery Technology Development

The two companies agreed to cooperate in the development of all-solid-state battery materials. In sample testing of materials from multiple suppliers, POSCO Future M demonstrated good rate capability.
Morningstar

Factorial and Cartesian Growth Corporation III (Nasdaq: CGCT) Announce Business Combination Agreement to Accelerate Commercialization of Solid-State Battery Technology

Factorial’s high-power, lightweight, solid-state batteries have demonstrated real-world performance, including over 1,200 km (745 miles) of driving range in vehicle testing and are being advanced ...
blockchain

Samsung’s Tiny Recursive Model (TRM) Outperforms Leading LLMs in Grid Puzzle AI Benchmarks

According to DeepLearning.AI, Samsung’s Tiny Recursive Model (TRM) utilizes iterative answer refinement and maintains a context of previous changes to tackle complex grid puzzles such as Sudoku, Mazes ...
GEN

Recursion, Roche Unveil Microglia Map of Neuro Disease Targets

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...
nai500

Nvidia-Backed AI Biotech Recursion Soars 25% in a Month: Time to Buy or Beware?

Amidst the AI boom transforming various sectors, Recursion Pharmaceuticals (NASDAQ: RXRX), a previously beaten-down AI-biotech, is showing signs of a rebound. Its stock has skyrocketed 25% in the past ...
The Motley Fool

Recursion Pharmaceuticals (RXRX) CEO Sells 100,000 Shares

Christopher Gibson, Chief Executive Officer of Recursion Pharmaceuticals, recently sold a significant chunk of his company's common stock. The CEO of Recursion Pharmaceuticals recently disposed of 120 ...
AOL

Where Will Recursion Pharmaceuticals Be in 5 Years?

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...